On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...